cardiovascular outcomes glp-1 news today and mortality with receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study | Diabetologia Effects of GLP‐1 receptor agonists

Research shows its more effective than oral glutathione alone, boosting glutathione levels and improving markers of healthy aging

Pfizer Develops Long-Acting GLP-1 Drug to Challenge Market Advertisement Felix Pfizer is developing a long-acting GLP-1 drug that could compete directly with established medications like Mounjaro and Zepbound when it reaches the Canadian market

This dual action may lead to different effects on body weight and blood glucose (sugar)

The researchers offered several possible biological explanations

Supplied as a sterile-filtered solution

A very high dose of 30 g shows little difference between males and females